-
TREATMENT EFFECT WANING ASSUMPTIONS VERSUS LONG-TERM EVIDENCE FOR IMMUNE CHECKPOINT INHIBITORS IN NICE'S SINGLE TECHNOLOGY APPRAISALS
Aug 11, 2026, 17:16 PM -
AN 8-POINT WORSENING AND A 10-POINT IMPROVEMENT ON THE MULTIPLE-SCLEROSIS IMPACT SCALE 29-ITEM (MSIS-29) V2 ARE CLINICALLY MEANINGFUL
Aug 11, 2026, 17:16 PM -
SURVIVAL OUTCOMES OF ABIRATERONE AND ENZALUTAMIDE IN THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: A SINGLE-CENTER RETROSPECTIVE ANALYSIS
Aug 11, 2026, 17:16 PM -
HOME NURSING CARE AND PATIENT SATISFACTION AMONG SINGLE ELDERLY PATIENTS
Aug 11, 2026, 17:16 PM -
SELECTING AND CO-DEVELOPING A DISEASE-SPECIFIC REFERENCE CASE EXTENSION FOR ADVANCED CANCER TO SUPPORT CONSISTENT HEALTH ECONOMIC MODELING ACROSS THE GUIDANCE LIFECYCLE
Aug 11, 2026, 17:16 PM -
BEYOND PHARMACEUTICAL VALUATION: A STANDARDIZED RISK-ADJUSTED NET PRESENT VALUE FRAMEWORK FOR CROSS-TECHNOLOGY INVESTMENT EVALUATION IN HEALTHCARE INNOVATION
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF VANCOMYCIN VERSUS DAPTOMYCIN VERSUS TEICOPLANIN IN THE MANAGEMENT OF BACTEREMIA IN JORDAN: A STUDY FROM PAYER PERSPECTIVE
Aug 11, 2026, 17:16 PM -
REAL-WORLD CLINICAL OUTCOMES AND HOSPITAL COSTS FOLLOWING LOWER-EXTREMITY BYPASS WITH AUTOLOGOUS VEIN VERSUS SYNTHETIC GRAFTS IN MEDICARE BENEFICIARIES WITH PERIPHERAL ARTERY DISEASE
Aug 11, 2026, 17:16 PM -
THE EFFECTS OF JANUS KINASE INHIBITORS ON PAIN IN RHEUMATOID ARTHRITIS: SUBANALYSIS OF A NETWORK META-ANALYSIS
Aug 11, 2026, 17:16 PM -
INFREQUENT AND LIMITED TO LITERATURE REVIEWS: AI USE IN NICE HTA SUBMISSIONS IN ONCOLOGY
Aug 11, 2026, 17:16 PM -
MAPPING THE LANDSCAPE OF CLINICAL GOVERNANCE MEASUREMENT: A GLOBAL SCOPING REVIEW OF INSTRUMENTS, APPLICATIONS, AND OUTCOMES
Aug 11, 2026, 17:16 PM -
VALUE ASSESSMENT OF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS IN CHINA: A RAPID HEALTH TECHNOLOGY ASSESSMENT
Aug 11, 2026, 17:16 PM -
A COST-CALCULATOR MODEL TO ESTIMATE THE ECONOMIC IMPACT OF OBINUTUZUMAB FOR THE TREATMENT OF LUPUS NEPHRITIS IN ITALY
Aug 11, 2026, 17:16 PM -
CLOSING THE GAP: QUANTIFYING MFN PRICING EXPOSURE AND STRATEGIC RESPONSES IN MEDICARE
Aug 11, 2026, 17:16 PM -
PULSE OXIMETRY MEASUREMENT ERROR, OCCULT HYPOXEMIA, AND ORGAN DYSFUNCTION ACROSS RACIAL AND ETHNIC GROUPS IN CRITICALLY ILL ADULTS IN UNITED STATES
Aug 11, 2026, 17:16 PM -
MAPPING FACILITATOR MECHANISMS TO POLICY BARRIERS TO DRUG REPURPOSING: AN ITERATIVE DEVELOPMENT OF MATCHED PAIR MATRIX
Aug 11, 2026, 17:16 PM -
QUANTIFYING THE ENVIRONMENTAL BURDEN OF LIPOPROTEIN APHERESIS IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA
Aug 11, 2026, 17:16 PM -
EARLY ACCESS, UNCERTAIN RETURNS: EAMS AND ITS INFLUENCE ON UK HTA OUTCOMES IN RARE DISEASES
Aug 11, 2026, 17:16 PM -
TREATMENT DURATION AND CLINICAL OUTCOMES WITH TUMOR TREATING FIELDS IN SWISS PATIENTS WITH GLIOBLASTOMA: A REAL-WORLD ANALYSIS
Aug 11, 2026, 17:16 PM -
ADHERENCE AS A VALUE SIGNAL: EMERGENCY DEPARTMENT UTILIZATION AND COST BURDEN ASSOCIATED WITH GLP-1 RA NON-ADHERENCE IN TYPE 2 DIABETES
Aug 11, 2026, 17:16 PM
